The drug development pipeline represents a remarkably lengthy and expensive undertaking. It typically begins with initial investigation efforts, often involving testing thousands of substances to identify potential drug candidates. Following this, initial evaluations are conducted in vitro and in vivo to assess safety and potency. Successful candid